A Northwestern Medicine physician identified a patient medication issue that ultimately led to an FDA labeling change


A woman with diabetes uses a glucometer to measure the glycemia in her blood in Paris on March 24, 2020, on the eighth day of a strict lockdown in France aimed at curbing the spread of COVID-19 caused by the novel coronavirus. (Photo by FRANCK FIFE / AFP) (Photo by FRANCK FIFE/AFP via Getty Images)

Dr. Emily Szmuilowicz, MD, endocrinologist, Northwestern Medicine Glenview Outpatient Center, joins Anna to talk about how she was able to help a patient resolve an issue with her blood disorder medication that ultimately led the FDA to make a change to the label.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Anna Davlantes
Weekdays 1-4pm AnnaDavlantes

Anna Davlantes is a Chicago native, a seven-time Emmy Award-winning journalist who has broken major stories, passionately told small stories and exposed corruption that has prompted major investigations and reform. (Click for more.)
More Home Page Top Stories